Mag Con: Efficacy of Oral Mag. in Acute Concussion in Adolescents

Concussion, Mild Clinical Trial

Official title: A Randomized Trial Evaluating the Efficacy of Oral Magnesium in Symptomatic Reduction of Acute Concussion in Adolescents

Status Withdrawn

Clinical Trial Summary

This randomized trial will compare the clinical efficacy of adding oral magnesium oxide to acetaminophen and ondansetron in the treatment of adolescents presenting within 48 hours of a mild traumatic brain injury using the Post-Concussion Symptom Severity Score Index.

Clinical Trial Description

This randomized trial will compare the clinical efficacy of oral magnesium oxide, acetaminophen and ondansetron, to that of PO acetaminophen and ondansetron in the treatment of adolescents presenting within 48 hours of a mild traumatic brain injury. Our primary endpoint will be to evaluate if magnesium has an impact on patient's Post-Concussion Symptom Severity Score Index. This will be evaluated both at the initial presentation in-person and then at 24, 48, and 72 hours via phone ;

Related Conditions & MeSH terms

• Brain Concussion
• Brain Injuries
• Brain Injuries, Traumatic
• Concussion, Mild

• NCT number: NCT05065528
• Study type: Interventional
• Source: Spectrum Health - Lakeland
• Status: Withdrawn
• Phase: N/A
• Start date: August 30, 2021
• Completion date: December 31, 2023